This guidance addresses key aspects of drug delivery performance information for devices, and combination products that include device constituent parts, intended for delivery of a human drug, including a biological product. The guidance describes FDA’s recommendations related to the device design outputs that are essential for establishing and assessing drug delivery performance. The guidance includes recommendations for the information and data to submit in investigational, marketing, and post-market change applications…
